CCO Treatment Updates

Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas

Module

Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas

Faculty:

Suzanne George, MD

CREDIT INFORMATION

Release Date: April 14, 2009

Expiration Date: April 13, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Suzanne George, MD, discusses optimal treatment strategies for sarcomas and reviews the latest clinical trials data on the incorporation of targeted agents and newer cytotoxic agents into the multimodal treatment of sarcoma.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the current limitations of treatment for advanced or metastatic sarcomas and the need for additional therapies
Apply clinical trials data evaluating the role of adjuvant chemotherapy according to histological subtype when treating patients with sarcoma
Describe the clinical evidence for using molecularly targeted therapies in sarcomas
Interpret the latest data on the safety and efficacy of novel targeted therapies for the treatment of sarcomas

Abstract

Click here to view abstract

Interactive Virtual Presentation

Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas

Faculty:

Suzanne George, MD

CREDIT INFORMATION

Release Date: April 22, 2009

Expiration Date: April 21, 2010

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Suzanne George MD gives an overview of established practice in treatment of soft tissue and bone sarcomas and then details the novel approaches using targeted therapies that are being incorporated into treatment of this group of diseases.

Learning Objectives

Upon completion of this activity, participants should be able to:

Relate the demographics and etiology of bone and soft tissue sarcomas
Discuss the standard therapeutic approaches for localized and advanced sarcomas
Explain the significance of the c-KIT mutation in gastrointestinal stromal tumors and how this has been exploited in therapy
Describe why the mammalian target of rapamycin pathway is a target for antineoplastic therapy and how this has been applied to sarcoma treatment

Slideset: Integrating Novel Approaches to Therapy into the Multidisciplinary Treatment of Sarcomas

Review an overview by Suzanne George MD of established practice in treatment of soft tissue and bone sarcomas and the novel approaches using targeted therapies that are being incorporated into treatment of this group of diseases.

Format: Microsoft PowerPoint (.ppt) | File size: 1.59 MB | Date posted: 4/22/2009

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.